"Treatment with intravenous remdesivir (a novel nucleotide analogue prodrug in development10,11) was initiated on the evening of day 7, and no adverse events we

"Treatment with intravenous remdesivir (a novel nucleotide analogue prodrug in development10,11) was initiated on the evening of day 7, and no adverse events were observed in association with the infusion. ... On hospital day 8 (illness day 12), the patient’s clinical condition improved. Supplemental oxygen was discontinued, ... "